Polygon Health Analytics Receives Competitive SBIR Grant from NIMHD to Address Health Disparities in Lupus Care
Philadelphia, PA — Nov 19, 2024 — Polygon Health Analytics LLC is proud to announce its award of a $295,924 Small…
Polygon Health Analytics Launches First Cohort of Launchpad Program
Polygon Health Analytics is excited to announce the successful graduation of the first cohort of its Launchpad Program, a 3-to-6-month train-to-hire…
Introducing Vaccine Vibes – A Weekly Newsletter for Vaccine R&D
Staying informed about the latest developments is critical for professionals in the biopharmaceutical industry, especially in the complex world of…
Polygon Health Analytics LLC Awarded $400,000 National Cancer Institute Contract
Philadelphia, PA – September 6, 2024 – Polygon Health Analytics LLC (PHA) is thrilled to announce that it has been awarded…
To My Fellow Data Scientists: Transform a Useful Idea into a Real Business
I have been building my own startup company for the past 1.5 years. Throughout this journey, I’ve been fortunate to…
Polygon Health Analytics to Present AI-driven chart review capabilities at ISPOR 2024
Polygon Health Analytics is proud to announce the development of a groundbreaking capability – a Large Language Model (LLM)-facilitated chart…
Navigating the Future: Your Launchpad to Success in Data Analytics
In today’s ever-evolving job market, the challenge of securing employment is a topic that resonates widely. Through news media and…
Bridging the Gap: Real-World Data Enhancing Clinical Trials
Randomized clinical trials (RCTs) have long been recognized as the gold standard for testing the safety and efficacy of pharmaceutical…
A Symphony of Innovation in 2023: Navigating the AI Revolution
Prelude to Power: OpenAI’s ChatGPT takes the lead In the waning months of 2022, OpenAI unveiled ChatGPT, marking a pivotal moment…
Polygon Health Analytics to Showcase Lupus Research at ACR 2023 Conference
Polygon Health Analytics will present two research projects on Systemic Lupus Erythematosus (SLE), through collaboration with Temple University and the…
FAQs about the FDA Guidance on the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
Analyzing real-world data (RWD)1 to generate real-world evidence (RWE)2 is an emerging trend in the healthcare community. RWE is routinely…
Leveraging Large Language Models like ChatGPT for Real-World Evidence Generation
Large Language Models (LLMs), including ChatGPT, have gained significant traction since late 2022, sparking debates about whether they’re mere hype…
Health Economics and Outcomes Research (HEOR): A Tool to Navigate the Biopharmaceutical Marathon
Congratulations! The decision to embark on the journey of founding a biopharmaceutical company is a courageous step indeed. Remember, as…
The Invisible Disease
“I got diagnosed in my early 20s” “I wanted to so badly say, ‘You guys have no idea. I’m in chemotherapy….
We Now Accepting Online Credit Card Payments for Client Convenience
online payment, credit card payment, fast services…
One drug, two Prices: Understanding the Role of Pharmacy Benefit Managers in US Drug Pricing
Humira, a top-selling drug with $200 billion in revenue over two decades, recently lost its patent monopoly. This paved the…
Damn, it is the data!
Artificial intelligence (AI), machine learning (ML), deep learning (DL), and natural language processing (NLP) are hard-to-avoid buzzwords at professional conferences,…